SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-040478
Filing Date
2024-04-02
Accepted
2024-04-02 18:10:42
Documents
1
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4800
  Complete submission text file 0000950170-24-040478.txt   6288
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Issuer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 490 LAPP ROAD MALVERN PA 19355
Business Address
Garner Charles (Reporting) CIK: 0001602444 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 24816084